Industry Insights Logo

Stretching Scarce Federal Resources: How Conway Medical Center Is Redefining 340B’s Impact

SPONSORED CONTENT

The purpose of the 340B drug pricing program remains a contested question between 340B providers and some in the pharmaceutical industry. In addition, there are questions regarding 340B’s scope including the contract pharmacy program and the definition of

Read More »
Industry Insights Logo

On Demand Webinar—What’s Next for Covered Entities? Navigating 340B Challenges and the Future of Patient Care

SPONSORED CONTENT

The 340B Drug Pricing Program is at a crossroads, facing increased scrutiny, manufacturer restrictions, and ongoing legal battles. In this must-watch webinar, industry experts Ted Slafsky (340B Report), Emily Cook (McDermott, Will & Emery), and Nicole Shoquist (JPS Health Network) break

Read More »
Industry Insights Logo

The Future of 340B in a Value-Based Care Era: Can It Survive and Thrive?

SPONSORED CONTENT

The healthcare system is undergoing a major transformation, with a growing emphasis on value-based care and outcomes-based payment models. These shifts aim to improve patient outcomes and reduce costs, fundamentally challenging traditional fee-for-service approaches. Against this backdrop,

Read More »
Industry Insights Logo

The Evolving Impact of 340B on Specialty Pharmacy

SPONSORED CONTENT

The 340B program continues to be a central topic of discussion in the pharmaceutical landscape, especially as specialty medications become an increasing portion of healthcare spending. Specialty pharmacies, covered entities (CEs), and manufacturers are navigating a complex environment shaped by regulatory

Read More »
Industry Insights Logo

Struggling with Low Pharmacy Capture Rates?

SPONSORED CONTENT

As a pharmacist and executive pharmacy leader, I nodded in affirmation when reading McKinsey & Company describe pharmacy services as a critical source of value for health centers and

Read More »
Industry Insights Logo

PBM is not a 4-letter word: How an independent PBM and an integrated pharmacy strategy provides value for your organization

SPONSORED CONTENT

Every dollar counts when you’re serving an underserved population. However, many organizations fail to incorporate a holistic approach to pharmacy and typically will separate pharmacy benefit management from pharmacy operations management. Creating an integrated

Read More »
Industry Insights Logo

Bridging the primary care gap: The role of in-house pharmacies in today’s healthcare marketplace

SPONSORED CONTENT

Healthcare leaders have a lot on their plates. Today’s healthcare landscape requires health care organizations to compete in attracting and retaining qualified employees, remain up to date on reimbursement changes, select and employ technologies to serve more patients

Read More »
Industry Insights Logo

Part 2 of 2: Understanding the Top Five Challenges Facing Health Center Pharmacies Today

SPONSORED CONTENT

Part 2 of 2: Navigating staffing shortages, unpredictable demand, and complex industry requirements

While in-house pharmacies offer a wide array of benefits both for the community health center (CHC) and

Read More »
Industry Insights Logo

Part 1 of 2: Understanding the Top Five Challenges Facing Health Center Pharmacies Today

SPONSORED CONTENT

Part 1 of 2: Managing costs and ensuring favorable contracting

As industry veterans know too well, having an in-house pharmacy can be greatly beneficial for both community health centers

Read More »
Industry Insights Logo

10 Questions to Ask Your 340B TPA about Your Contract and Fees

SPONSORED CONTENT

If you have one or more agreements with 340B Third Party Administrator(s) (TPA) to manage your contract pharmacy arrangements, how much do you know about those contracts and associated fees?  Chances are, you don’t know the answers to all the questions that

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Site Footer Live